Bacillus probiotics

Food Microbiology

Volumn 28, Issue 2, 2011, Pages 214-220

  Cutting, Simon M ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bacillus; Feed supplements; Probiotics; Spores

Indexed keywords

PROBIOTIC AGENT;

ANIMAL; ANIMAL FOOD; BACILLUS; BACTERIAL SPORE; DIET SUPPLEMENTATION; FOOD CONTROL; HUMAN; MICROBIOLOGY; PHYSIOLOGY; PRODUCT SAFETY; REVIEW;

ANIMAL FEED; ANIMALS; BACILLUS; CONSUMER PRODUCT SAFETY; DIETARY SUPPLEMENTS; FOOD MICROBIOLOGY; HUMANS; PROBIOTICS; SPORES, BACTERIAL;

ANIMALIA; BACILLI (CLASS); BACILLUS (BACTERIUM); BACTERIA (MICROORGANISMS);

EID: 79551719109     PISSN: 07400020     EISSN: 10959998     Source Type: Journal    
DOI: 10.1016/j.fm.2010.03.007     Document Type: Review

References (72)

1. Agnew M.D., Koval S.F., Jarrell K.F. Isolation and characterisation of novel alkaliphiles from bauxite-processing waste and description of Bacillus vedderi sp. nov., a new obligate alkaliphile. Syst. Appl. Microbiol. 1995, 18:221-230.
2. Araya M., Morelli L., Reid G., Sanders M.E., Stanton C. Joint FAO/WHO Working Group Report on Guidelines for the Evaluation of Probiotics in Food 2002, London, Ontario. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
3. Barbosa T.M., Serra C.R., La Ragione R.M., Woodward M.J., Henriques A.O. Screening for Bacillus isolates in the broiler gastrointestinal tract. Appl. Environ. Microbiol. 2005, 71:968-978.
4. Bilev A.E. Comparative evaluation of probiotic activity in respect to in vitro pneumotropic bacteria and pharmacodynamics of biosporin-strain producers in patients with chronic obstructive pulmonary diseases. Voen. Med. Zh. 2002, 323:54-57.
5. Bozdogan B., Galopin S., Leclereq R. Characterization of a new erm-related macrolide resistance gene present in probiotic strains of Bacillus clausii. Appl. Environ. Microbiol. 2004, 70:280-284.
6. Ciffo F. Determination of the spectrum of antibiotic resistance of the Bacillus subtilis strains of Enterogermina. Chemioterapia 1984, 3:45-52.
7. Ciprandi G., Tosca M.A., Milanese M., Caligo G., Ricca V. Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: a pilot study. Pediatr. Allergy Immunol. 2004, 15:148-151.
8. Ciprandi G., Vizzaccaro A., Cirillo I., Tosca M.A. Bacillus clausii effects in children with allergic rhinitis. Allergy 2005, 60:702-703.
9. Ciprandi G., Vizzaccaro A., Cirillo I., Tosca M.A. Bacillus clausii exerts immuno-modulatory activity in allergic subjects: a pilot study. Eur. Ann. Allergy Clin. Immunol. 2005, 37:129-134.
10. Coppi F., Ruoppolo M., Mandressi A., Bellorofonte C., Gonnella G., Trinchieri A. Results of treatment with Bacillus subtilis spores (Enterogermina) after antibiotic therapy in 95 patients with infection calculosis. Chemioterapia 1985, 4:467-470.
11. D'Arienzo R., Maurano F., Mazzarella G., Luongo D., Stefanile R., Ricca E., Rossi M. Bacillus subtilis spores reduce susceptibility to Citrobacter rodentium-mediated enteropathy in a mouse model. Res. Microbiol. 2006, 157:891-897.
12. de Boer A.S., Diderichsen B. On the safety of Bacillus subtilis and B. amyloliquefaciens: a review. Appl. Microbiol. Biotechnol. 1991, 36:1-4.
13. Drago L., De Vecchi E. Should Lactobacillus sporogenes and Bacillus coagulans have a future?. J. Chemother. 2009, 21:371-377.
14. Duc L.H., Fraser P., Cutting S.M. Carotenoids present in halotolerant Bacillus spore formers. FEMS Microbiol. Lett. 2006, 255:215-224.
15. Endres J.R., Clewell A., Jade K.A., Farber T., Hauswirth J., Schauss A.G. Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food Chem. Toxicol. 2009.
16. Errington J. Regulation of endospore formation in Bacillus subtilis. Nat. Rev. Microbiol. 2003, 1:117-126.
17. Fakhry S., Sorrentini I., Ricca E., De Felice M., Baccigalupi L. Characterization of spore forming Bacilli isolated from the human gastrointestinal tract. J. Appl. Microbiol. 2008, 105:2178-2186.
18. Fiorini G., Cimminiello C., Chianese R., Visconti G.P., Cova D., Uberti T., Gibelli A. Bacillus subtilis selectively stimulates the synthesis of membrane bound and secreted IgA. Chemioterapia 1985, 4:310-312.
19. Fritze D., Pukall R. Reclassification of bioindicator strains Bacillus subtilis DSM 675 and Bacillus subtilis DSM 2277 as Bacillus atrophaeus. Int. J. Syst. Evol. Microbiol. 2001, 51:35-37.
20. Green D.H., Wakeley P.R., Page A., Barnes A., Baccigalupi L., Ricca E., Cutting S.M. Characterization of two Bacillus probiotics. Appl. Environ. Microbiol. 1999, 65:4288-4291.
21. Henriques A.O., Moran C.P. Structure, assembly, and function of the spore surface layers. Annu. Rev. Microbiol. 2007, 61:555-588.
22. Hoa N.T., Baccigalupi L., Huxham A., Smertenko A., Van P.H., Ammendola S., Ricca E., Cutting S.M. Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl. Environ. Microbiol. 2000, 66:5241-5247.
23. Hoa T.T., Duc L.H., Isticato R., Baccigalupi L., Ricca E., Van P.H., Cutting S.M. Fate and dissemination of Bacillus subtilis spores in a murine model. Appl. Environ. Microbiol. 2001, 67:3819-3823.
24. Hong H.A., Duc le H., Cutting S.M. The use of bacterial spore formers as probiotics. FEMS Microbiol. Rev. 2005, 29:813-835.
25. Hong H.A., Huang J.-M., Khaneja R., Hiep L.V., Urdaci M.C., Cutting S.M. The safety of Bacillus subtilis and Bacillus indicus as food probiotics. J. Appl. Microbiol. 2008, 105:510-520.
26. Hong H.A., Khaneja R., Tam N.M., Cazzato A., Tan S., Urdaci M., Brisson A., Gasbarrini A., Barnes I., Cutting S.M. Bacillus subtilis isolated from the human gastrointestinal tract. Res. Microbiol. 2009, 160:134-143.
27. Hong H.A., To E., Fakhry S., Baccigalupi L., Ricca E., Cutting S.M. Defining the natural habitat of Bacillus spore-formers. Res. Microbiol. 2009.
28. Hong, A.H., Duc, H.L., Cutting, S.M. Immunogenicity and intracellular fate of Bacillus subtilis spores. Microbiology, submitted for publication.
29. Hosoi T., Kiuchi K. Production and probiotic effects of Natto. Horizon Bioscience 2004, 143-154. Wymondham, UK. E. Ricca, A.O. Henriques, S.M. Cutting (Eds.).
30. Hyronimus B., Le Marrec C., Urdaci M.C. Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. J. Appl. Microbiol. 1998, 85:42-50.
31. Ishibashi N., Yamazaki S. Probiotics and safety. Am. J. Clin. Nutr. 2001, 73:465S-470S.
32. Khaneja R., Perez-Fons L., Fakhry S., Baccigalupi L., Steiger S., To E., Sandmann G., Dong T.C., Ricca E., Fraser P.D., Cutting S.M. Carotenoids found in Bacillus. J. Appl. Microbiol. 2009.
33. La Ragione R.M., Casula G., Cutting S.M., Woodward M. Bacillus subtilis spores competitively exclude Escherichia coli 070:K80 in poultry. Vet. Microbiol. 2001, 79:133-142.
34. La Ragione R.M., Woodward M.J. Competitive exclusion by Bacillus subtilis spores of Salmonella enterica serotype Enteritidis and Clostridium perfringens in young chickens. Vet. Microbiol. 2003, 94:245-256.
35. Li Z., Kawamura Y., Shida O., Yamagata S., Deguchi T., Ezaki T. Bacillus okuhidensis sp. nov., isolated from the Okuhida spa area of Japan. Int. J. Syst. Evol. Microbiol. 2002, 52:1205-1209.
36. Logan N.A. Safety of aerobic endospore-forming bacteria. Horizon Bioscience 2004, 93-106. Norfolk, UK. E. Ricca, A.O. Henriques, S.M. Cutting (Eds.).
37. Mandel D.R., Eichas K., Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement. Altern. Med. 2010, 10:1.
38. Marseglia G.L., Tosca M., Cirillo I., Licari A., Leone M., Marseglia A., Castellazzi A.M., Ciprandi G. Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study. Ther. Clin. Risk Manag. 2007, 3:13-17.
39. Mazza G. Genetic studies on the transfer of antibiotic resistance genes in Bacillus subtilis strains. Chemioterapia 1983, 2:64-72.
40. Mazza P. The use of Bacillus subtilis as an antidiarrhoeal microorganism. Boll. Chim. Farm. 1994, 133:3-18.
41. Mazza P., Zani F., Martelli P. Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy. Boll. Chim. Farm. 1992, 131:401-408.
42. Mitchell C., Iyer S., Skomurski J.F., Vary J.C. Red pigment in Bacillus megaterium spores. Appl. Environ. Microbiol. 1986, 52:64-67.
43. Moir A. How do spores germinate?. J. Appl. Microbiol. 2006, 101:526-530.
44. Nakamura L.K. Taxonomic relationship of black-pigmented Bacillus subtilis strains and a proposal for Bacillus atrophaeus sp. nov. Int. J. Syst. Bacteriol. 1989, 39:295-300.
45. Nicholson W.J., Munakata N., Horneck G., Melosh H.J., Setlow P. Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol. Mol. Biol. Rev. 2000, 64:548-572.
46. Nielsen P., Fritze D., Priest F.G. Phenetic diversity of alkaliphilic Bacillus strains: proposal for nine new species. Microbiology 1995, 141:1745-1761.
47. Nista E.C., Candelli M., Cremonini F., Cazzato I.A., Zocco M.A., Franceschi F., Cammarota G., Gasbarrini G., Gasbarrini A. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment. Pharmacol. Ther. 2004, 20:1181-1188.
48. Osipova I.G., Sorokulova I.B., Tereshkina N.V., Grigor'eva L.V. Safety of bacteria of the genus Bacillus, forming the base of some probiotics. Zh Mikrobiol Epidemiol. Immunobiol 1998, 6:68-70.
49. Osipova I.G., Makhailova N.A., Sorokulova I.B., Vasil'eva E.A., Gaiderov A.A. Spore probiotics. Zh. Mikrobiol. Epidemiol. Immunobiol. 2003, 113-119.
50. Osipova I.G., Sorokulova I.B., Vasil'eva E.A., Budanova E.V. Pre-clinical trials of new spore probiotics. Vestn. Ross. Akad. Med. Nauk 2005, 36-40.
51. Pane L., Radin L., Franconi G., Carli A. The carotenoid pigments of a marine Bacillus firmus strain. Boll. Soc. Ital Biol. Sper. 1996, 72:303-308.
52. Pinchuk I.V., Bressollier P., Verneuil B., Fenet B., Sorokulova I.B., Megraud F., Urdaci M.C. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob. Agents Chemother. 2001, 45:3156-3161.
53. Rhee K.J., Sethupathi P., Driks A., Lanning D.K., Knight K.L. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 2004, 172:1118-1124.
54. Ruger H.-J., Koploy J.A.C. DNA base composition of halophilic and nonhalophilkic Bacillus firmus strains of marine origin. Microb. Ecol. 1980, 6:141-146.
55. Sanders M.E., Morelli L., Tompkins T.A. Sporeformers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Compr. Rev. Food Sci. Food Saf. 2003, 2:101-110.
56. SCAN Opinion of the Scientific Committee on Animal Nutrition on the Safety of the Use of Bacillus Species in Animal Nutrition 2000, European Commission, Health and Consumer Protection Directorate-General. (SCAN) Scientific Committee on Animal Nutrition.
57. ® for Use as Feed Additive 2000, European Commission, Health and Consumer Protection Directorate-General. (SCAN) Scientific Committee on Animal Nutrition.
58. ® for Use as Feed Additive 2001, European Commission, Health and Consumer Protection Directorate-General. (SCAN) Scientific Committee on Animal Nutrition.
59. ® for Use as Feed Additive 2001, European Commission, Health and Consumer Protection Directorate-General. (SCAN) Scientific Committee on Animal Nutrition.
60. Senesi S., Celandroni F., Tavanti A., Ghelardi E. Molecular characterization and identification of Bacillus clausii strains marketed for use in oral bacteriotherapy. Appl. Environ. Microbiol. 2001, 67:834-839.
61. Sorokulova I.B. A comparative study of the biological properties of Biosporin and other commercial Bacillus-based preparations. Mikrobiol. Zh. 1997, 59:43-49.
62. Sorokulova I.B., Beliavskaia V.A., Masycheva V.A., Smirnov V.V. Recombinant probiotics: problems and prospects of their use for medicine and veterinary practice. Vestn. Ross. Akad. Med. Nauk 1997, 46-49.
63. Sorokulova I.B., Pinchuk I.V., Denayrolles M., Osipova I.G., Huang J.M., Cutting S.M., Urdaci M.C. The safety of two Bacillus probiotic strains for human use. Dig. Dis. Sci. 2008, 53:954-963.
64. Spinosa M.R., Braccini T., Ricca E., De Felice M., Morelli L., Pozzi G., Oggioni M.R. On the fate of ingested Bacillus spores. Res. Microbiol. 2000, 151:361-368.
65. Stenfors Arnesen L.P., Fagerlund A., Granum P.E. From soil to gut: Bacillus cereus and its food poisoning toxins. FEMS Microbiol. Rev. 2008, 32:579-606.
66. Sumi H., Hamada H., Tsushima H., Mihara H., Muraki H. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet. Experientia 1987, 43:1110-1111.
67. Sumi H., Yatagai C., Wada H., Yoshida E., Maruyama M. Effect of Bacillus natto-fermented product (BIOZYME) on blood alcohol, aldehyde concentrations after whisky drinking in human volunteers, and acute toxicity of acetaldehyde in mice. Arukoru Kenkyuto Yakubutsu Ison 1995, 30:69-79.
68. Suresh K., Prabagaran S.R., Sengupta S., Shivaji S. Bacillus indicus sp. nov., an arsenic-resistant bacterium isolated from an aquifer in West Bengal, India. Int. J. Syst. Evol. Microbiol. 2004, 54:1369-1375.
69. Tam N.K., Uyen N.Q., Hong H.A., Duc le H., Hoa T.T., Serra C.R., Henriques A.O., Cutting S.M. The intestinal life cycle of Bacillus subtilis and close relatives. J. Bacteriol. 2006, 188:2692-2700.
70. Tuohy K.M., Pinart-Gilberga M., Jones M., Hoyles L., McCartney A.L., Gibson G.R. Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. J. Appl. Microbiol. 2007, 102:1026-1032.
71. Yoon J.H., Kang S.S., Lee K.C., Kho Y.H., Choi S.H., Kang K.H., Park Y.H. Bacillus jeotgali sp. nov., isolated from jeotgal, Korean traditional fermented seafood. Int. J. Syst. Evol. Microbiol. 2001, 51:1087-1092.
72. Yoon J.H., Lee C.H., Oh T.K. Bacillus cibi sp. nov., isolated from jeotgal, a traditional Korean fermented seafood. Int. J. Syst. Evol. Microbiol. 2005, 55:733-736.